Personalized Integrated Network Modeling of the Cancer Proteome Atlas
暂无分享,去创建一个
Veerabhadran Baladandayuthapani | Rehan Akbani | Han Liang | Kim-Anh Do | Sayantan Banerjee | Min Jin Ha | Gordon B. Mills | G. Mills | K. Do | R. Akbani | V. Baladandayuthapani | Sayantan Banerjee | Han Liang | M. Ha
[1] P. Sorger,et al. Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks , 2012, Cell.
[2] Prahlad T. Ram,et al. A pan-cancer proteomic perspective on The Cancer Genome Atlas , 2014, Nature Communications.
[3] Alfonso Valencia,et al. EnrichNet: network-based gene set enrichment analysis , 2012, Bioinform..
[4] Eli Upfal,et al. Algorithms for Detecting Significantly Mutated Pathways in Cancer , 2010, RECOMB.
[5] William C. Hahn,et al. Towards systematic functional characterization of cancer genomes , 2011, Nature Reviews Genetics.
[6] Seon-Young Kim,et al. PAGE: Parametric Analysis of Gene Set Enrichment , 2005, BMC Bioinform..
[7] Markus List,et al. KeyPathwayMinerWeb: online multi-omics network enrichment , 2016, Nucleic Acids Res..
[8] Yiling Lu,et al. Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays. , 2017, Cancer cell.
[9] Marino E. Leon,et al. Tumor-to-Tumor Metastasis: Renal Cell Carcinoma Metastatic to Papillary Carcinoma of Thyroid—Report of a Case and Review of the Literature , 2009, Head and neck pathology.
[10] Peng Qiu,et al. TCGA-Assembler: open-source software for retrieving and processing TCGA data , 2014, Nature Methods.
[11] Jan Baumbach,et al. De novo pathway-based biomarker identification , 2017, Nucleic acids research.
[12] Pooja Mittal,et al. A novel signaling pathway impact analysis , 2009, Bioinform..
[13] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[14] Steven J. M. Jones,et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. , 2015, The New England journal of medicine.
[15] F. Markowetz,et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.
[16] Andrew M. Gross,et al. Network-based stratification of tumor mutations , 2013, Nature Methods.
[17] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[18] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[19] David Haussler,et al. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..
[20] J. Berger,et al. Optimal predictive model selection , 2004, math/0406464.
[21] Andrea Califano,et al. Rewiring makes the difference , 2011, Molecular systems biology.
[22] Sourav Bandyopadhyay,et al. Rewiring of Genetic Networks in Response to DNA Damage , 2010, Science.
[23] David Venet,et al. Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome , 2011, PLoS Comput. Biol..
[24] Aleix Prat Aparicio. Comprehensive molecular portraits of human breast tumours , 2012 .
[25] T. Pawson,et al. Oncogenic re-wiring of cellular signaling pathways , 2007, Oncogene.
[26] Amin Allahyar,et al. FERAL: network-based classifier with application to breast cancer outcome prediction , 2015, Bioinform..
[27] Peter J. Woolf,et al. GAGE: generally applicable gene set enrichment for pathway analysis , 2009, BMC Bioinformatics.
[28] R. Peck,et al. The right dose for every patient: a key step for precision medicine , 2015, Nature Reviews Drug Discovery.
[29] N. Meinshausen,et al. Stability selection , 2008, 0809.2932.
[30] David Haussler,et al. PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis , 2012, Bioinform..
[31] M. Tuveri,et al. Renal cell carcinoma metastasis to thyroid tumor: a case report and review of the literature , 2013, Journal of Medical Case Reports.
[32] Jan Baumbach,et al. On the performance of de novo pathway enrichment , 2017, npj Systems Biology and Applications.
[33] Peter Bühlmann,et al. Causal stability ranking , 2011, Bioinform..
[34] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[35] M. Horattas,et al. Metastatic renal cell carcinoma to the thyroid gland. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[36] Tobias Müller,et al. Bioinformatics Applications Note Systems Biology Bionet: an R-package for the Functional Analysis of Biological Networks , 2022 .
[37] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[38] Rehan Akbani,et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. , 2017, Cancer cell.
[39] M. Stratton,et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. , 2013, Blood.
[40] J. Brugarolas. PBRM1 and BAP1 as novel targets for renal cell carcinoma. , 2013, Cancer journal.
[41] Francesco C Stingo,et al. Bayesian nonlinear model selection for gene regulatory networks , 2015, Biometrics.
[42] Peter Bühlmann,et al. Estimating High-Dimensional Directed Acyclic Graphs with the PC-Algorithm , 2007, J. Mach. Learn. Res..
[43] Steven J. M. Jones,et al. Integrated Genomic Characterization of Papillary Thyroid Carcinoma , 2014, Cell.
[44] Robert Tibshirani,et al. Estimating the number of clusters in a data set via the gap statistic , 2000 .
[45] Tso-Jung Yen,et al. Discussion on "Stability Selection" by Meinshausen and Buhlmann , 2010 .